Neuralink
Neuralink: authorizing a study is not approving a product
Neuralink said it had received fda authorization to begin its first human study. The source bounds the event: the statement was not commercial approval, demonstrated efficacy, open recruitment or patient availability. The story teaches how to distinguish study authorization, protocol, recruitment, implant, clinical endpoint, follow-up and approval.
3 min